Domestic consumer electronics giant TCL Group is seeking to turn to the field of medical electronics. Following the acquisition of Beijing Sinopharm Hengrui Meilian Co., Ltd., TCL yesterday, together with Haoran Capital’s Shikangrong Medical Group, announced the establishment of a joint venture to establish TCL Medical Group, which is mainly engaged in a series of high-quality medical images including X-ray, ultrasound equipment, DSA, CT and MRI. Diagnosing the production and sales of products, and Hengrui Meilian will also be integrated into a subsidiary of TCL Medical Group. Yesterday, Hu Hai, general manager of TCL Medical Group, said that the new company was registered in Guangzhou. It is not convenient to disclose the investment amount because it will soon add registered capital and working capital. In TCL Medical Group, TCL Group is the controlling shareholder and Shikangrong Medical is a minority shareholder. The board of directors of the company will be from the TCL Group, TCL Medical System (ie Hengrui Meilian) and Shi Kangrong Medical Tripartite Executives. The founder and chairman of Shi Kangrong Medical, Chen Zhi will serve as the chairman of the joint venture company, TCL Hu Hai, general manager of the medical group, will serve as general manager. As early as 2009, TCL proposed a plan to intervene in the medical electronics market in the group's annual report, and said that it will extend its competitiveness in the field of digital image processing technology to the field of medical electronics. Then in October 2009, TCL Group spent a total of 51.31 million yuan to acquire Beijing Sinopharm Hengrui Meilian Information Technology Co., Ltd. and renamed it TCL Medical System. At present, Hengrui Meilian mainly develops and produces X-ray products. However, it is worth noting that this transaction also has a dollar fund Haoran Capital. Haoran Capital once controlled Shikangrong Medical in 2009 and used it as a platform to acquire two medical imaging development consumables companies in China. At present, Haoran Capital manages about 500 million US dollars of funds. The medical device field is gradually attracting the attention of multi-party capital including industrial capital. In 2011, Safran Investment Fund and Haina Asia invested in Beijing Huiying Internet Technology and Aotai Medical, respectively. Among them, Huiying Medical specializes in magnetic resonance, color ultrasound and mobile digital imaging solutions, while the latter focuses on magnetic resonance imaging. System product. According to the data of Zero2IPO, in 2011, there were 33 investment cases in the field of medical devices in China. According to the statistics of the National Development and Reform Commission, as of September last year, China's medical equipment industry in 2011 had a total industrial output value of 98.5 billion yuan, while the industrial sales revenue in 2011 reached 135.427 billion yuan, an increase of 26.6% compared with the same period of the previous year. Xu Tianhong, a partner of Pangu Chuangfu Investment Medical Fund, believes that from the perspective of the return on venture capital of various sub-sectors in the medical and health field, the highest is found in the pharmaceutical industry, followed by medical devices, while medical services and medical IT are relatively backward. However, at present, China's medical device market adopts a “follow-up strategy†to copy foreign products at a lower price. Xiaoke, an analyst at the Zero2IPO Research Center, told this reporter that the domestic high-end medical device market has been monopolized by international giants such as Philips, GE and Siemens; while the local medical device sector is mainly for the production of disposable hospitals due to technical and financial thresholds. Consumables, low-end inspection and testing equipment. Middle and low-end medical device products, including sanitary materials, disposable hospital supplies, ventilators, general and laser surgical instruments, account for about 75% of the entire medical device market. From the perspective of equipment application, many small and medium-sized hospitals mainly use domestically produced low-end products, while large hospitals import more high-end equipment, showing an obvious "pyramid" shape.
mainly from person to person through respiratory droplets. Respiratory droplets travel into the air when you cough, sneeze, talk, shout, or sing. These droplets can then land in the mouths or noses of people who are near you or they may breathe these droplets in.
Masks are a simple barrier to help prevent your respiratory droplets from reaching others. Studies show that masks reduce the spray of droplets when worn over the nose and mouth.
You should wear a mask, even if you do not feel sick. This is because several studies have found that people with COVID-19 who never develop symptoms (asymptomatic) and those who are not yet showing symptoms (pre-symptomatic) can still spread the virus to other people. Wearing a mask helps protect those around you, in case you are infected but not showing symptoms.
Face Shield,Custom Medical Shield,Protective Mining Face Mask,Protection Face Shield Suzhou Xuanweicheng Biotechnology Co., Ltd , https://www.xwc-medical.com